Purdue Pharma announced it will cease marketing its controversial painkiller, OxyContin, to U.S. doctors, marking a significant shift in its business practices. This decision follows years of scrutiny over the role the drug played in the opioid crisis. Purdue's move comes as part of a larger effort to resolve legal challenges and rebuild its public image. In related news, many are now focusing on efforts to extract urls from xml file for better transparency. The company is also working to extract URLs from XML files to improve information accessibility.